Friday, 16 October 2026European Markets

SLIGRO FOOD GROUP And J.MARTINS,SGPS Have A High Dividend Yield And Return On Equity In The Food Distribution Industry.

Loading stream...

(VIANEWS) - SLIGRO FOOD GROUP (SLIGR.AS) is among this list of stock assets with the highest dividend rate and return on equity on the Food Distribution industry.

Financial Asset Price Forward Dividend Yield Return on Equity
SLIGRO FOOD GROUP (SLIGR.AS) €14.40 3.73% 3.6%
J.MARTINS,SGPS (JMT.LS) €22.26 2.32% 28.68%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. SLIGRO FOOD GROUP (SLIGR.AS)

3.73% Forward Dividend Yield and 3.6% Return On Equity

Sligro Food Group N.V. engages in the foodservice businesses in the Netherlands and Belgium. The company offers a range of food and food-related non-food products; and services in the food and beverages wholesale market. It operates a network of cash-and-carry and delivery service sites to serve hospitality industry, leisure facilities, caterers, large-volume users, company restaurants, petrol stations, small and medium-sized enterprises, small retail businesses, and the institutional markets under the Sligro, De Kweker, and Van Hoeckel brand names in the Netherlands. It also serves institutional, corporate catering, and hotel chain segments under the JAVA Foodservice name; and hospitality industry, culinary professionals, and wholesale delivery service outlets under the Silgro-ISPC name through a network of two cash-and-carry and delivery service sites. In addition, the company is involved in the production of convenience and fresh fish products; sourcing of meat, game and poultry, fruits and vegetables, and bread and pastries; advertise, design, delivery, install, and maintenance of professional kitchen, kitchen equipment, and refrigeration and freezing equipment; and provision of online gift concepts and Christmas gifts, and traditional Christmas hampers. It also offers its products through online platform. Sligro Food Group N.V. was founded in 1935 and is headquartered in Veghel, the Netherlands.

Earnings Per Share

As for profitability, SLIGRO FOOD GROUP has a trailing twelve months EPS of €0.35.

PE Ratio

SLIGRO FOOD GROUP has a trailing twelve months price to earnings ratio of 41.14. Meaning, the purchaser of the share is investing €41.14 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.6%.

Yearly Top and Bottom Value

SLIGRO FOOD GROUP's stock is valued at €14.40 at 06:40 EST, under its 52-week low of €15.04.

More news about SLIGRO FOOD GROUP.

2. J.MARTINS,SGPS (JMT.LS)

2.32% Forward Dividend Yield and 28.68% Return On Equity

Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal. In addition, it operates restaurants under the Pingo Doce name; Bem-Estar pharmacies; petrol stations; and clothing under Code brand. Further, the company operates kiosks and coffee shops under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; the purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; and provision of economic and accounting, business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. operates as a subsidiary of Sociedade Francisco Manuel Dos Santos, S.G.P.S., S.A.

Earnings Per Share

As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €1.16.

PE Ratio

J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 19.19. Meaning, the purchaser of the share is investing €19.19 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.68%.

Moving Average

J.MARTINS,SGPS's value is way below its 50-day moving average of €25.16 and higher than its 200-day moving average of €22.05.

More news about J.MARTINS,SGPS.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com